Stroke Prevention in Atrial Fibrillation III "SPAF III"

Completed

Phase N/A Results

Summary of Purpose

To compare low-intensity, fixed-dose warfarin plus aspirin with conventional adjusted-dose warfarin in patients with atrial fibrillation (AF) at high risk of stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 September 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Institute for Neurological Disorders and Stroke, NIH

Trial Design

Randomized, clinical trial of 1044 patients at 20 centers in USA and Canada.

Contacts

  • Ruth McBride, SPAF Statistical Center, Statistics and Epidemiology Research Corporation, 1107 NE 45th St., Suite 520, Seattle, WA 98105, USA

    hartr@uthscsa.edu